SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Medical - Healthcare >

Epigenomics (EPGNF)

EPGNF RSS Feed
Add EPGNF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 5/5/2014 4:45:33 PM - Followers: 0 - Board type: Free - Posts Today: 0

FDA approval is just around Who we are We are a molecular diagnostics company developing and commercializing a pipeline of proprietary products for the screening and diagnosis of cancer. Our products enable doctors to diagnose cancer earlier and more accurately, leading to improved outcomes for patients. Our lead product, Epi proColon®, is a blood-based test for the early detection of colorectal cancer, which is currently marketed in Europe and is in development for the U.S.A.. Our technology and products have been validated through multiple partnerships with leading global diagnostic companies and testing laboratories. We are an international company with operations in Europe and the U.S.A. Epigenomics: US study suggests blood-based Septin9 CRC screening could save lives and be health-economically beneficial Last UPDATE 22.07.2013 CRC screening with blood-based Septin9 tests has potential to improve screening uptake and adherence rates Septin9 testing could decrease colorectal cancer (CRC) incidence by 41% and CRC mortality by 61% at optimal screening uptake rates Septin9 based screening shown to be cost-effective over no screening Berlin, Germany, and U.S.A., July 22, 2013 - Epigenomics AG (Frankfurt Prime Standard: ECX), the German-American cancer molecular diagnostics company, today announced findings from a health economic study by Prof. Uri Ladabaum, M.D., M.S., et al. from the Division of Gastroenterology and Hepatology, Stanford University School of Medicine, USA.
SureTrader
Interactive Brokers Advertisement
EPGNF
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
PostSubject
#13   China permitting on the way 2015 harry74nrw 05/05/14 04:45:33 PM
#12   sorry, wrong thread jupp 10/03/13 04:11:48 PM
#11   Patriot Wins Patent Infringement Suit Against HTC Corporation jupp 10/03/13 04:08:33 PM
#10   19.08.2013 Epigenomics AG secures financing of up to jupp 08/19/13 03:47:40 AM
#9   Epigenomics – Conference Call on August 7, 2013 jupp 08/10/13 06:17:15 PM
#8   Epigenomics (GM) Aktienkurs OTC- EPGNF jupp 08/09/13 03:28:25 AM
#7   Don`t know what's going wrong. jupp 08/08/13 10:14:02 AM
#6   If its in effect to trade, why we kraziman09 07/26/13 09:15:48 AM
#5   Epigenomics: US study suggests blood-based Septin9 CRC screening jupp 07/25/13 12:01:24 PM
#4   Epigenomics Establishes American Depositary Receipt (ADR) Program jupp 07/25/13 11:55:24 AM
#3   no trading here why? when will this be penny runner 07/23/13 09:39:20 AM
#2   Epigenomics receives notification of priority review status and jupp 07/22/13 05:41:41 AM
#1   A good Storry. jupp 07/22/13 05:37:35 AM
PostSubject